- PodcastEpisode 66Duration 38:31
Howie and Harlan discuss Howie’s recent bout of COVID-19 and the takeaways from new research on adverse events in hospitals, and they consider claims from Tucker Carlson of Fox News about the pandemic response.
- PodcastEpisode 65Duration 34:58
Howie and Harlan are joined by Leora Horwitz, director of the Rapid Randomized Controlled Trial Lab at NYU Langone Health, to discuss her work using experimentation to improve the delivery of care, and her experience as a clinician and researcher in the chaotic first months of the COVID-19 outbreak in New York City. Harlan reports on his new study examining the impact on patients of early-morning blood draws in hospitals; Howie reflects on new business models for delivering discounted generic drugs.
- PodcastEpisode 64Duration 33:04
Howie and Harlan talk with Gil Addo, CEO and co-founder of RubiconMD, which is aiming to expand access to specialty care by providing virtual consultations to primary care physicians. A new study from Harlan examines a loophole that is allowing unreliable medical devices to enter the market; Howie provides an update on legislature that will soon cause millions to lose Medicaid coverage.
- PodcastEpisode 63Duration 35:33
Howie and Harlan check in on health issues that are in the news—or will be soon. Harlan discusses his work measuring patient outcomes and new avenues of research on long COVID; Howie reports on the perverse effects of private equity investment in specialty healthcare practices and the looming deadline facing state Medicaid programs.
- PodcastEpisode 62Duration 36:10
Harlan answers questions about the cardiac arrest suffered by Buffalo Bills player Damar Hamlin in a nationally televised football game; Howie reports on the rapid spread of the XBB 1.5 variant of COVID-19. And they are joined by F. Perry Wilson, a Yale nephrologist and an expert in the translation of medical research into clinical care, to discuss his new book, How Medicine Works and When It Doesn’t: Learning Who to Trust to Get and Stay Healthy.
- PodcastEpisode 61Duration 36:42
Howie and Harlan are joined by Lisa Sanders, the Yale internist who writes the "Diagnosis" column in the New York Times. Harlan reports on new studies demonstrating the ineffectiveness of ivermectin in treating COVID-19, and the effectiveness of the bivalent booster in improving outcomes. And Howie reacts to headlines about frequent misdiagnoses in emergency departments.
- PodcastEpisode 60Duration 33:16
Harlan reports on a new study suggesting dramatic health benefits from bursts of vigorous activity; Howie explains how genetic science is starting to illuminate a mystery in his own medical history. And they are joined by Yale physician and scientist Jeffrey Gruen to discuss his work identifying the genetic variants associated with dyslexia and designing early interventions for kids with learning disabilities.
- PodcastEpisode 59Duration 36:09
Harlan reports on new research on effective prostate cancer screening; Howie explores the potential of the AI language model ChatGPT. And they’re joined by Dr. Kristen Nwanyanwu, a Yale ophthalmologist with a focus on closing the racial gap in the treatment of diabetic retinopathy.
- PodcastEpisode 58Duration 34:18
Howie and Harlan are joined by Dr. Eric Topol, a physician and writer who is widely recognized both as a leading researcher and a public voice on medicine and health. They discuss his career turn toward genomics and digital health, and the fight against misinformation on Twitter.
- PodcastEpisode 57Duration 34:07
Harlan reports on a unprecedented recall of ventilators and CPAP machines; Howie discusses a new approach to tackling the issue of antimicrobial resistance. And they’re joined by Dr. Nancy Brown, dean of the Yale School of Medicine, to discuss her career path and her investments in developing talent.